Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 3, 2025, with respect to the financial statements of Edgewise Therapeutics, Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference.
/s/ KPMG LLP
Denver, Colorado
March 3, 2025
